Searching for genetic modulators of the phenotypic heterogeneity in Brugada syndrome.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 27 08 2021
accepted: 20 01 2022
entrez: 1 3 2022
pubmed: 2 3 2022
medline: 11 3 2022
Statut: epublish

Résumé

In Brugada syndrome, even within the same family where all affected individuals share the same mutation, phenotypic variation is prominent, with variable penetrance and expressivity, presenting different degrees of involvement. It is difficult to establish a direct correlation between genotype and phenotype to predict prognosis in complications and risk of sudden death. The factors that modulate this inter- and intra-familial phenotypic variability remain to be determined. With the intention of testing whether other genetic factors, in addition to the causal mutation in SCN5A, may have a modulating effect on the Brugada phenotype and the risk of sudden death, we have studied 8 families with a causal variant in SCN5A with at least two affected individuals, one of whom has suffered cardiac arrest or sudden death. Whole exome sequencing was performed looking for additional variants that modify the phenotype and allow us to predict a better or worse prognosis for the evolution of the disease. The results did not show any clear genetic modifier; nevertheless, highlight the possible implication of the cholesterol and fibrosis pathways, as well as the circadian rhythm, as possible modulators of Brugada syndrome phenotype.

Identifiants

pubmed: 35231055
doi: 10.1371/journal.pone.0263469
pii: PONE-D-21-27865
pmc: PMC8887717
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0263469

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Biomed J. 2019 Aug;42(4):252-260
pubmed: 31627867
J Am Coll Cardiol. 2018 Aug 28;72(9):1046-1059
pubmed: 30139433
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Aug;1865(8):158706
pubmed: 32247032
Bioinformatics. 2018 Jun 15;34(12):2144-2146
pubmed: 29438558
EBioMedicine. 2020 Jul;57:102843
pubmed: 32645615
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
J Cardiovasc Electrophysiol. 2019 Jan;30(1):128-131
pubmed: 30375078
J Am Coll Cardiol. 2015 Nov 3;66(18):1976-1986
pubmed: 26516000
Front Physiol. 2018 Aug 10;9:1088
pubmed: 30147658
Front Physiol. 2021 Jan 14;11:611860
pubmed: 33519516
J Mol Cell Cardiol. 1995 Jun;27(6):1263-9
pubmed: 8531208
Circulation. 2005 Nov 1;112(18):2769-77
pubmed: 16267250
Am J Physiol Cell Physiol. 2013 May 15;304(10):C954-65
pubmed: 23364267
Circulation. 2007 Jun 19;115(24):3130-8
pubmed: 17576883
J Hypertens. 2000 Jun;18(6):655-73
pubmed: 10872549
Hypertension. 2007 Feb;49(2):241-8
pubmed: 17190878
Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H1036-47
pubmed: 18156197
Heart Rhythm. 2019 Feb;16(2):298-307
pubmed: 30170229
Circulation. 2005 Dec 13;112(24):3680-7
pubmed: 16344400
J Cardiovasc Electrophysiol. 2011 Sep;22(9):1073-6
pubmed: 21288276
Int J Mol Sci. 2020 Nov 13;21(22):
pubmed: 33202810
Heart Rhythm. 2015 Jun;12(6):1333-42
pubmed: 25701775
Circulation. 2019 Aug 13;140(7):595-610
pubmed: 31403841
Cell Physiol Biochem. 2011;27(3-4):299-304
pubmed: 21471719
Circ Cardiovasc Genet. 2009 Dec;2(6):552-7
pubmed: 20031634
PLoS One. 2016 Sep 29;11(9):e0163514
pubmed: 27684715
J Clin Invest. 2018 Mar 1;128(3):1154-1163
pubmed: 29457789
HeartRhythm Case Rep. 2016 Aug 02;2(6):465-468
pubmed: 28491738
J Mol Cell Cardiol. 2014 Nov;76:126-9
pubmed: 25172307
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
J Mol Cell Cardiol. 2017 Jan;102:74-82
pubmed: 27894866
Nat Genet. 2013 Sep;45(9):1044-9
pubmed: 23872634
J Mol Med (Berl). 2004 Apr;82(4):256-64
pubmed: 14985853
Cardiol J. 2018;25(1):113-119
pubmed: 28980288
Science. 2012 Sep 7;337(6099):1190-5
pubmed: 22955828
Subcell Biochem. 2010;51:509-49
pubmed: 20213557
J Am Heart Assoc. 2016 Sep 13;5(9):
pubmed: 27625342
Nat Rev Genet. 2017 Mar;18(3):164-179
pubmed: 27990019
Int J Mol Sci. 2020 Sep 28;21(19):
pubmed: 32998306
Int J Mol Sci. 2021 Feb 04;22(4):
pubmed: 33557237
Cardiovasc Res. 2021 Jul 27;117(9):2092-2107
pubmed: 32898233
Heart Rhythm. 2018 Aug;15(8):1179-1188
pubmed: 29574140
Int J Mol Sci. 2020 Mar 01;21(5):
pubmed: 32121523
Cardiovasc Res. 2011 Sep 1;91(4):606-16
pubmed: 21705349

Auteurs

Laura Martínez-Campelo (L)

Cardiovascular Genetics, Santiago de Compostela Health Research Institute, Santiago de Compostela, Spain.
Genomic Medicine Group, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

Raquel Cruz (R)

Genomic Medicine Group, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
CIBER of Rare Diseases, Carlos III Health Institute, Madrid, Spain.

Alejandro Blanco-Verea (A)

Cardiovascular Genetics, Santiago de Compostela Health Research Institute, Santiago de Compostela, Spain.
Genomic Medicine Group, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

Isabel Moscoso (I)

Cardiovascular CIBER, Carlos III Health Institute, Madrid, Spain.
Cardiology Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

Eva Ramos-Luis (E)

Cardiovascular Genetics, Santiago de Compostela Health Research Institute, Santiago de Compostela, Spain.
Genomic Medicine Group, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

Ricardo Lage (R)

Cardiovascular CIBER, Carlos III Health Institute, Madrid, Spain.
Cardiology Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

María Álvarez-Barredo (M)

Cardiovascular Genetics, Santiago de Compostela Health Research Institute, Santiago de Compostela, Spain.
Cardiovascular CIBER, Carlos III Health Institute, Madrid, Spain.

María Sabater-Molina (M)

Cardiovascular CIBER, Carlos III Health Institute, Madrid, Spain.
Cardiogenetics Laboratory, Murcian Institute for Biosanitary Research, Cardiology Service, Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain.

Pablo Peñafiel-Verdú (P)

Cardiovascular CIBER, Carlos III Health Institute, Madrid, Spain.
Cardiogenetics Laboratory, Murcian Institute for Biosanitary Research, Cardiology Service, Virgen de la Arrixaca University Clinical Hospital, Murcia, Spain.

Juan Jiménez-Jáimez (J)

Cardiovascular CIBER, Carlos III Health Institute, Madrid, Spain.
Arrhythmia Unit, Virgen de las Nieves University Hospital, Granada, Spain.

Moisés Rodríguez-Mañero (M)

Cardiovascular CIBER, Carlos III Health Institute, Madrid, Spain.
Cardiology Service, Santiago de Compostela University Hospital, Santiago de Compostela, Spain.

María Brion (M)

Cardiovascular Genetics, Santiago de Compostela Health Research Institute, Santiago de Compostela, Spain.
Genomic Medicine Group, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
Cardiovascular CIBER, Carlos III Health Institute, Madrid, Spain.
Family Heart Disease Unit, Cardiology Service, Santiago de Compostela University Hospital, Santiago de Compostela, Spain.

Articles similaires

Humans Brugada Syndrome Atrial Fibrillation Death, Sudden, Cardiac Male
Humans Male Antimalarials Brugada Syndrome Artemisinins
Brugada Syndrome Humans Prognosis Electrophysiologic Techniques, Cardiac Risk Assessment

Classifications MeSH